Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 2 (2005), Issue 2 (February)

1. Theragnostic imaging for radiation oncology: dose-painting by numbers.
   Lancet Oncol, 6(2): 112-7. [Abstract] [Full-text]
2. Repositioning accuracy of fractionated stereotactic irradiation: assessment of isocentre alignment for different dental fixations by using sequential CT scanning.
   Radiother Oncol, 74(1): 61-6. [Abstract] [Full-text]
3. Treatment accuracy of fractionated stereotactic radiotherapy.
   Radiother Oncol, 74(1): 53-9. [Abstract] [Full-text]
4. Tomotherapy planning of small brain tumours.
   Radiother Oncol, 74(1): 49-52. [Abstract] [Full-text]
5. High precision conformal radiotherapy employing conservative margins in childhood benign and low-grade brain tumours.
   Radiother Oncol, 74(1): 37-44. [Abstract] [Full-text]
6. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study.
   Radiother Oncol, 74(1): 3-9. [Abstract] [Full-text]
7. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
   Cancer, 103(3): 538-45. [Abstract] [Full-text]
8. Optimal timing of preoperative radiation for prophylaxis against heterotopic ossification. A rabbit hip model.
   J Bone Joint Surg Am, 87(2): 366-73. [Abstract] [Full-text]
9. 131I-tositumomab therapy as initial treatment for follicular lymphoma.
   N Engl J Med, 352(5): 441-9. [Abstract] [Full-text]
10. Intracranial extramedullary hematopoiesis: brief review of response to radiation therapy.
    Am J Hematol, 78(2): 151-2. [Abstract] [Full-text]
11. The effect of pre-operative conventional and hyperfractionated radiotherapy schedules on wound healing and tensile strength in rats: an experimental study.
    Int J Oral Maxillofac Surg, 34(2): 185-92. [Abstract] [Full-text]
12. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.
    Int J Oral Maxillofac Surg, 34(2): 114-21. [Abstract] [Full-text]
13. Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart.
    Cancer Lett, 219(1): 41-8. [Abstract] [Full-text]
14. Radio-immunotherapy in low-grade non-Hodgkin's lymphoma.
    Best Pract Res Clin Haematol, 18(1): 81-95. [Abstract] [Full-text]
15. Synthesis and cellular studies of an octa-anionic 5,10,15,20-tetra[3,5-(nido-carboranylmethyl)phenyl]porphyrin (H(2)OCP) for application in BNCT.
    Bioorg Med Chem, 13(5): 1633-40. [Abstract] [Full-text]
16. Management of skin reactions during radiotherapy: a study of nursing practice.
    Eur J Cancer Care (Engl), 14(1): 28-42. [Abstract] [Full-text]
17. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation.
    J Clin Endocrinol Metab, 90(2): 689-94. [Abstract] [Full-text]
18. Vacuum application increases therapeutic safety and allows intensified local radiation treatment of malignant soft-tissue tumors.
    Strahlenther Onkol, 181(2): 124-30. [Abstract] [Full-text]
19. Hyperbaric oxygen and radiotherapy.
    Strahlenther Onkol, 181(2): 113-23. [Abstract] [Full-text]
20. Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edge.
    Strahlenther Onkol, 181(2): 108-12. [Abstract] [Full-text]
21. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base.
    Strahlenther Onkol, 181(2): 97-107. [Abstract] [Full-text]
22. Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality.
    Strahlenther Onkol, 181(2): 89-96. [Abstract] [Full-text]
23. Peripheral dose measurement with a MOSFET detector.
    Appl Radiat Isot, 62(4): 631-4. [Abstract] [Full-text]
24. Dependence of radiochromic film response kinetics on fractionated doses.
    Appl Radiat Isot, 62(4): 609-17. [Abstract] [Full-text]
25. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease.
    Neuro-oncol, 7(1): 64-76. [Abstract] [Full-text]
26. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.
    Br J Cancer, 92(3): 488-98. [Abstract] [Full-text]
27. Cardiovascular effects of radiation therapy: practical approach to radiation therapy-induced heart disease.
    Cardiol Rev, 13(2): 80-6. [Abstract] [Full-text]
28. Brachytherapy-related dysuria.
    BJU Int, 95(4): 597-602. [Abstract] [Full-text]
29. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
    BJU Int, 95(4): 534-40. [Abstract] [Full-text]
30. In vivo dosimetry of high-dose-rate brachytherapy: study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter.
    Int J Radiat Oncol Biol Phys, 61(3): 945-53. [Abstract] [Full-text]
31. Adequate margins for random setup uncertainties in head-and-neck IMRT.
    Int J Radiat Oncol Biol Phys, 61(3): 938-44. [Abstract] [Full-text]
32. Accuracy of a wireless localization system for radiotherapy.
    Int J Radiat Oncol Biol Phys, 61(3): 933-7. [Abstract] [Full-text]
33. Hybrid IMRT plans--concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time.
    Int J Radiat Oncol Biol Phys, 61(3): 922-32. [Abstract] [Full-text]
34. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies.
    Int J Radiat Oncol Biol Phys, 61(3): 830-41. [Abstract] [Full-text]
35. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study.
    Int J Radiat Oncol Biol Phys, 61(3): 824-9. [Abstract] [Full-text]
36. The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.
    Int J Radiat Oncol Biol Phys, 61(3): 779-88. [Abstract] [Full-text]
37. Customized conformal high-dose-rate brachytherapy boost for limited-volume nasopharyngeal cancer.
    Int J Radiat Oncol Biol Phys, 61(3): 754-61. [Abstract] [Full-text]
38. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.
    Int J Radiat Oncol Biol Phys, 61(3): 702-13. [Abstract] [Full-text]
39. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
    Int J Radiat Oncol Biol Phys, 61(3): 678-86. [Abstract] [Full-text]
40. Management of supratentorial cavernous malformations: craniotomy versus gammaknife radiosurgery.
    Clin Neurol Neurosurg, 107(2): 108-12. [Abstract] [Full-text]
41. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation.
    Am J Transplant, 5(3): 537-43. [Abstract] [Full-text]
42. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.
    Cancer, 103(4): 793-801. [Abstract] [Full-text]
43. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.
    J Vasc Interv Radiol, 16(2): 205-13. [Abstract] [Full-text]
44. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
    J Vasc Interv Radiol, 16(2): 195-203. [Abstract] [Full-text]
45. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Brain, 128: 570-83. [Abstract] [Full-text]
46. Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines.
    Support Care Cancer, 13(2): 122-8. [Abstract] [Full-text]
47. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
    J Clin Oncol, 23(6): 1237-44. [Abstract] [Full-text]
48. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).
    J Clin Oncol, 23(6): 1200-8. [Abstract] [Full-text]
49. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate.
    J Clin Oncol, 23(6): 1192-9. [Abstract] [Full-text]
50. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Gynecol Oncol, 96(3): 818-23. [Abstract] [Full-text]
51. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Gynecol Oncol, 96(3): 665-70. [Abstract] [Full-text]
52. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas.
    Head Neck, 27(3): 182-6. [Abstract] [Full-text]
53. Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy.
    Head Neck, 27(3): 187-94. [Abstract] [Full-text]
54. Cortical laminar necrosis in childhood intracranial germ cell tumor survivors.
    Pediatr Blood Cancer, 44(4): 412-5. [Abstract] [Full-text]
55. Intracranial germinoma: on whole-ventricular irradiation.
    Pediatr Blood Cancer, 44(4): 358-62. [Abstract] [Full-text]
56. The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease.
    Stereotact Funct Neurosurg, 82(5): 254-62. [Abstract] [Full-text]
57. Long-term follow-up of trigeminal neuralgia treatment using a linear accelerator.
    Stereotact Funct Neurosurg, 82(5): 244-9. [Abstract] [Full-text]
58. Quality assurance in stereotactic radiosurgery/radiotherapy according to DIN 6875-1.
    Stereotact Funct Neurosurg, 82(5): 235-43. [Abstract] [Full-text]
59. S(+)-ketamine for long-term sedation in a child with retinoblastoma undergoing interstitial brachytherapy.
    Paediatr Anaesth, 15(3): 248-50. [Abstract] [Full-text]
60. Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child.
    Paediatr Anaesth, 15(3): 241-2. [Abstract] [Full-text]
61. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
    Cancer, 103(5): 1008-17. [Abstract] [Full-text]
62. Construction of a remote radiotherapy planning system.
    Int J Clin Oncol, 10(1): 26-9. [Abstract] [Full-text]
63. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
    J Neurooncol, 71(3): 319-23. [Abstract] [Full-text]
64. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.
    J Neurooncol, 71(3): 307-13. [Abstract] [Full-text]
65. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    J Neurooncol, 71(3): 287-93. [Abstract] [Full-text]
66. Assessing perfusion changes during whole brain irradiation for patients with cerebral metastases.
    J Neurooncol, 71(3): 281-6. [Abstract] [Full-text]
67. Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer.
    J Clin Oncol, 23(7): 1538-47. [Abstract] [Full-text]
68. Measurements and treatment planning calculations of electron dose distributions below bolus edges.
    Radiother Oncol, 74(2): 217-20. [Abstract] [Full-text]
69. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.
    Radiother Oncol, 74(2): 203-10. [Abstract] [Full-text]
70. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy.
    Radiother Oncol, 74(2): 187-95. [Abstract] [Full-text]
71. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer.
    Radiother Oncol, 74(2): 177-85. [Abstract] [Full-text]
72. The design and testing of a solid phantom for the verification of a commercial 3D seed reconstruction algorithm.
    Radiother Oncol, 74(2): 169-75. [Abstract] [Full-text]
73. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer.
    Radiother Oncol, 74(2): 157-61. [Abstract] [Full-text]
74. A dosimetric intercomparison of brachytherapy facilities in Ireland, Scotland and the North of England.
    Radiother Oncol, 74(2): 149-56. [Abstract] [Full-text]
75. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.
    Radiother Oncol, 74(2): 137-48. [Abstract] [Full-text]
76. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Radiother Oncol, 74(2): 131-6. [Abstract] [Full-text]
77. Quantification of dose perturbation by plaque in vascular brachytherapy.
    Eur J Clin Invest, 35(3): 180-5. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.